The immune parameters matched the stroke outcome in that the PD-L1-/- and to a lesser extent PD-L2-/- had reduced levels of proinflammatory activated microglia and/or infiltrating monocytes and CD4+ T cells in the ischemic hemispheres. This evidence concerns the gene PDCD1LG2 and Stroke.